Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine.
about
Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic diseaseRandomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer painEfficacy and adverse effects of transdermal fentanyl and sustained-release oral morphine in treating moderate-severe cancer pain in Chinese population: a systematic review and meta-analysisSleep quality, the neglected outcome variable in clinical studies focusing on locomotor system; a construct validation studyMethylnaltrexone: the evidence for its use in the management of opioid-induced constipation.Treatment options to manage pain at the end of life.Topical nonsteroidal anti-inflammatory drugs for the treatment of pain due to soft tissue injury: diclofenac epolamine topical patch.Assessment and management of chronic pain in elderly people.Current aproach to cancer pain management: Availability and implications of different treatment options.Analgesia for patients with advanced disease: ILong-term use of a once-a-day fentanyl citrate transdermal patch in lung cancer patientsTransdermal buprenorphine in the treatment of chronic pain.A review of opioid prescription in a teaching hospital in Colombia.Dermal and transdermal drug delivery systems: current and future prospects.Measures of fibromyalgia: Fibromyalgia Impact Questionnaire (FIQ), Brief Pain Inventory (BPI), Multidimensional Fatigue Inventory (MFI-20), Medical Outcomes Study (MOS) Sleep Scale, and Multiple Ability Self-Report Questionnaire (MASQ).Multicenter clinical study for evaluation of efficacy and safety of transdermal fentanyl matrix patch in treatment of moderate to severe cancer pain in 474 chinese cancer patients.The role of transdermal fentanyl patches in the effective management of cancer pain.Transdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review.Pharmacological Management of Cancer-Related Pain.Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients.Inefficacy of high-dose transdermal fentanyl in a patient with neuropathic pain, a case report.The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients.Beyond informed consent: the ethical design of pain research.Efficacy of fentanyl transdermal patch in pain control after lower third molar surgery: A preliminary study.Opioid-induced bowel dysfunction.Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.Intravenous morphine can avoid distressing constipation associated with oral morphine: a retrospective analysis of our experience in 11 patients in the palliative care in-patient unit.Analgesic effect of switching from oral opioids to a once-a-day fentanyl citrate transdermal patch in patients with lung cancer.Preconditioning with hydrogen sulfide prevents bone cancer pain in rats through a proliferator-activated receptor gamma/p38/Jun N-terminal kinase pathway.The memorial symptom assessment scale short form (MSAS-SF).Influence of aprepitant and localization of the patch on fentanyl exposure in patients with cancer using transdermal fentanyl.
P2860
Q24792437-5270E577-09AB-40E2-85D4-A747484FED8FQ28364765-2FCEC831-5B5D-4CA1-9D90-A044CCD88318Q33597167-893C1232-E805-40AF-9C49-160907D906F6Q33709617-2B2FE7DB-60AE-4CC2-838C-4483A5CB9D50Q33973870-9ED428C3-C879-4C2A-B782-985807CBFA0FQ34283168-16037795-BE07-4CA9-BF13-28BC1C77FA11Q34418290-96581E5D-1681-4A91-8C8F-BCCDF59206B8Q34779114-0D01E46F-4157-42BB-AC67-C7B20DDFD802Q34779398-F1B2D236-BB59-4910-8EA4-C0166E9FC357Q35518956-E33A9918-88B0-4ABA-9A26-9974ADACDF8DQ35714829-57DD223C-16EA-4CA7-8559-2D948360B91DQ36153362-FBDB6483-607F-4470-945F-62845314448CQ36235096-E4EBA492-2440-4E7A-B9B4-3AE7AD93F170Q36429878-94ABDAD0-E5D2-4904-B1EF-868B17919DCAQ36480034-87E11B91-8E1D-419B-A556-A50F1D3B9FCAQ36551093-69FC334D-D451-4AC2-B46B-C2880C937FA7Q37569516-5E55592D-A9E2-4508-A235-375AC821323AQ38399076-7A46A28F-FCC3-4FB3-859A-FA29EA99CAE5Q38672359-F7995E73-D8C3-4540-8C99-04F66ED11F45Q39406202-A6502C3E-30F6-4196-9889-5D05CABEFF34Q39414637-7CFF2C23-AA50-4ABE-98B3-9AB7376A83C1Q40449086-F926983B-E256-4857-8343-2B74B37823C5Q40515650-2B44E9E9-D4AC-4C2E-BB44-83B80B50A88BQ40976853-31A8D9FB-3AD5-42A4-92DB-8035D6D14E8EQ42323281-BFB9D9C0-CAC4-49AA-B51D-5CEBA4AECC03Q42602071-583B3564-320E-4521-93F0-E65C73819AAAQ44515265-DF125A18-9F28-479C-890E-8FB7EBC55286Q48104630-33F30664-5B05-4CA2-8BC2-7DB96392BF05Q48613524-D2CA35A9-7216-445D-9723-447F643A284AQ53514186-25F8EB69-0C4E-4986-A520-9BEA1407A45AQ53681128-42C50C1C-3CB2-48FD-B155-F70EEA11A5E5
P2860
Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine.
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Quality of life and cancer pai ...... fentanyl versus oral morphine.
@ast
Quality of life and cancer pai ...... fentanyl versus oral morphine.
@en
Quality of life and cancer pai ...... fentanyl versus oral morphine.
@nl
type
label
Quality of life and cancer pai ...... fentanyl versus oral morphine.
@ast
Quality of life and cancer pai ...... fentanyl versus oral morphine.
@en
Quality of life and cancer pai ...... fentanyl versus oral morphine.
@nl
prefLabel
Quality of life and cancer pai ...... fentanyl versus oral morphine.
@ast
Quality of life and cancer pai ...... fentanyl versus oral morphine.
@en
Quality of life and cancer pai ...... fentanyl versus oral morphine.
@nl
P2093
P1476
Quality of life and cancer pai ...... fentanyl versus oral morphine.
@en
P2093
P304
P356
10.1200/JCO.1998.16.4.1588
P407
P577
1998-04-01T00:00:00Z